Product Catalog [{"id":"469","name":"Yupelri","price":1,"sku":"Yupelri (revefenacin)","brand":"Theravance Biopharma","position":19,"category":"Medicines"},{"id":"468","name":"Roszet","price":1,"sku":"Roszet (rosuvastatin and ezetimibe)","brand":"Althera Life Sciences","position":20,"category":"Medicines"},{"id":"467","name":"Zegalogue","price":1,"sku":"Zegalogue (dasiglucagon)","brand":"Zeeland Pharma","position":21,"category":"Medicines"},{"id":"466","name":"Nexviazyme","price":1,"sku":"Nexviazyme (avalglucosidase alfa)","brand":"Sanofi","position":22,"category":"Medicines"},{"id":"465","name":"Vocabria","price":1,"sku":"Vocabria (cabotegravir)","brand":"ViiV Healthcare","position":23,"category":"Medicines"},{"id":"464","name":"Cabenuva","price":1,"sku":"Cabenuva (cabotegravir + rilpivirine)","brand":"ViiV Healthcare","position":24,"category":"Medicines"},{"id":"463","name":"Evaluation of Parsaclisib plus Bendamustine and Rituximab in patients with Newly Diagnosed Mantle Cell Lymphoma","price":1,"sku":"lymphoma-trial-2","brand":false,"position":25,"category":"Medicines"},{"id":"462","name":"Evaluation of Tafasitamab plus Rituximab and Lenalidomide in patients with Lymphoma that has stopped responding to treatment","price":1,"sku":"lymphoma-trial-3","brand":false,"position":26,"category":"Medicines"},{"id":"461","name":"Evaluation of Parsaclisib plus Rituximab or Obinutuzumab in patients with Lymphoma that has stopped responding to treatment","price":1,"sku":"lymphoma-trial-4","brand":false,"position":27,"category":"Medicines"}]

Medicine access options

View as Grid List

Items 25-36 of 254

per page
Set Descending Direction
CA